Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.36
+0.0000
Post-market: 3.360.00000.00%16:05 EDT
Volume:131.75K
Turnover:438.07K
Market Cap:201.20M
PE:-4.51
High:3.41
Open:3.38
Low:3.27
Close:3.36
Loading ...
Mar 15, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]